Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

Documenti analoghi

• Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
  di: C. Guardo, Alberto, et al.
  Pubblicazione: (2017)
• The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens
  di: Gómez, Carmen Elena, et al.
  Pubblicazione: (2011)
• A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
  di: Gómez, Carmen Elena, et al.
  Pubblicazione: (2015)
• Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B
  di: Couto, Elvira, et al.
  Pubblicazione: (2019)
• The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses
  di: Pérez, Patricia, et al.
  Pubblicazione: (2021)